Company / Free Cash Flow per Share
ABEONA THERAPEUTICS INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.85
FY2025
5-year range
-$11.86 / -$0.38
FY2021-FY2025
Trend
-31.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-11.86 in FY2022 to $-0.38 in FY2021.
Based on SEC 10-K filings.
-1.85 in FY2025.
Improved from $-2.46 to $-1.85 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 31.2% year-over-year.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.85 | -31.2% |
| FY2024 | -$1.41 | +42.8% |
| FY2023 | -$2.46 | +79.2% |
| FY2022 | -$11.86 | -3035.3% |
| FY2021 | -$0.38 | +54.3% |
| FY2020 | -$0.83 | -68.6% |
| FY2019 | -$0.49 | +52.4% |
| FY2018 | -$1.03 | -76.5% |
| FY2017 | -$0.58 | -50.2% |
| FY2016 | -$0.39 | +53.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026